Market Tracker

07/22 6:45pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

125.80
Delayed Data
As of Jul 22
 -1.50 / -1.18%
Today’s Change
110.56
Today|||52-Week Range
208.88
-34.05%
Year-to-Date
I Just Bought These 4 Fast-Growing Biotech Stocks
Jul 23 / MotleyFool.com - Paid Partner Content
Why Alexion Pharmaceuticals, Inc. Stock Sank 23.5% in June
Jul 14 / MotleyFool.com - Paid Partner Content
3 Stocks Dragging In The Drugs Industry
Jul 22 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Juno In and Out of Clinical Hold, Amgen Biosimilar Gets Panel ...
Jul 13 / Zacks.com - Paid Partner Content
Sorry, You Can't Buy This Hot Biotech -- At Least Not Directly
Jul 21 / MotleyFool.com - Paid Partner Content
20 stocks to buy after Brexit chaos
Jun 28 / CNNMoney.com
Earnings Estimates for These 3 Biotech Giants Should Be Heading Lower -- Here's Why
Jul 19 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close127.30
Today’s open127.74
Day’s range125.34 - 127.98
Volume1,381,823
Average volume (3 months)1,846,804
Market cap$28.2B
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-79.45%
Earnings growth (this year)+1.17%
Earnings growth (next 5 years)+23.38%
Revenue growth (last year)+12.25%
P/E ratio192.4
Price/Sales16.57
Price/Book3.44

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.12+0.24%
MYLMylan NV-0.27-0.58%
VRTXVertex Pharmaceutica...+0.68+0.73%
INCYIncyte Corp-1.38-1.57%
Data as of 4:04pm ET, 07/22/2016

Financials

Last reporting dateJuly 21, 2016
EPS forecast (this quarter)$1.18
Annual revenue (last year)$2.5B
Annual profit (last year)$144.4M
Net profit margin5.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
Cheshire, Connecticut

Forecasts